资讯

Targeted Oncology1 小时
Key Molecular Testing Remains Critical in GIST Management
Breelyn Wilky, MD, discusses what key molecular insights in GIST management community oncologists should prioritize today.
Chiang Rai Times17 小时
Thailand Achieves Cancer Treatment Milestone With Imcranib 100
Thailand has taken a major step in its healthcare journey as the Chulabhorn Royal Academy (CRA) launches Imcranib 100 for ...
Targeted Oncology21 小时
Similar Survival and Safety for Ripretinib and Sunitinib INTRIGUE Study Says
Final analysis of the INTRIGUE trial shows ripretinib offers similar survival rates and better safety compared to sunitinib ...